Literature DB >> 12965203

Chp-1 and melusin, two CHORD containing proteins in vertebrates.

Mara Brancaccio1, Nadia Menini, Daniela Bongioanni, Roberta Ferretti, Marika De Acetis, Lorenzo Silengo, Guido Tarone.   

Abstract

Melusin is a muscle specific protein required for heart hypertrophy in response to mechanical overload. Here we describe a protein 63% homologous to melusin, named chp-1, expressed in all tissues tested, including muscles, and highly conserved from invertebrates to human. Both proteins are characterized in their N-terminal half by a tandemly repeated zinc binding 60 amino acid domain with a motif of uniquely spaced cysteine and histidine residues. These motives are highly conserved from plants to mammals and have been recently named CHORD (for cysteine and histidine rich domain) domains. At the C-terminal end melusin contains a calcium binding stretch of 30 acidic amino acid residues which is absent in chp-1. While invertebrate genome contains only one gene coding for a chp-1 homolog, two genes coding for CHORD containing proteins (chp-1 and melusin) are present in vertebrates. Sequence analysis suggests that the muscle specific CHORD containing protein melusin originated by a gene duplication event during early chordate evolution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965203     DOI: 10.1016/s0014-5793(03)00892-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  The zinc-binding protein chordc1 undergoes complex diurnal changes in mRNA expression during mouse brain development.

Authors:  Jason R Gerstner; Charles F Landry
Journal:  Neurochem Res       Date:  2007-01-26       Impact factor: 3.996

2.  A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein.

Authors:  Jacob J Gano; Julian A Simon
Journal:  Mol Cell Proteomics       Date:  2009-10-28       Impact factor: 5.911

3.  MicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 protein.

Authors:  Fanpeng Zhao; Gang Xu; Yaqin Zhou; Lvyin Wang; Jiajia Xie; Sheng Ren; Shi Liu; Ying Zhu
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

4.  Profiles of novel diurnally regulated genes in mouse hypothalamus: expression analysis of the cysteine and histidine-rich domain-containing, zinc-binding protein 1, the fatty acid-binding protein 7 and the GTPase, ras-like family member 11b.

Authors:  J R Gerstner; W M Vander Heyden; T M Lavaute; C F Landry
Journal:  Neuroscience       Date:  2006-03-06       Impact factor: 3.590

5.  SGT1 is essential for Nod1 activation.

Authors:  Jean da Silva Correia; Yvonne Miranda; Nikki Leonard; Richard Ulevitch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

6.  Dynamic nucleotide-dependent interactions of cysteine- and histidine-rich domain (CHORD)-containing Hsp90 cochaperones Chp-1 and melusin with cochaperones PP5 and Sgt1.

Authors:  Tae-Joon Hong; Sangkyu Kim; Ah Ram Wi; Peter Lee; Miae Kang; Jae-Hoon Jeong; Ji-Sook Hahn
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

7.  Structural basis for assembly of Hsp90-Sgt1-CHORD protein complexes: implications for chaperoning of NLR innate immunity receptors.

Authors:  Minghao Zhang; Yasuhiro Kadota; Chrisostomos Prodromou; Ken Shirasu; Laurence H Pearl
Journal:  Mol Cell       Date:  2010-07-30       Impact factor: 17.970

Review 8.  The double face of Morgana in tumorigenesis.

Authors:  Mara Brancaccio; Stefania Rocca; Laura Seclì; Elena Busso; Federica Fusella
Journal:  Oncotarget       Date:  2015-12-15

9.  An evolutionarily conserved protein CHORD regulates scaling of dendritic arbors with body size.

Authors:  Kohei Shimono; Kazuto Fujishima; Takafumi Nomura; Masayoshi Ohashi; Tadao Usui; Mineko Kengaku; Atsushi Toyoda; Tadashi Uemura
Journal:  Sci Rep       Date:  2014-03-19       Impact factor: 4.379

Review 10.  Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia.

Authors:  Stefania Rocca; Giovanna Carrà; Pietro Poggio; Alessandro Morotti; Mara Brancaccio
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.